MoneyWorks4Me

Trident Lifeline makes additional investment in subsidiary

17 Apr 2025 Evaluate

Trident Lifeline has made an additional investment in its subsidiary -- TNS PHARMA by acquiring 10,20,000 equity shares. Consequently, the company’s total shareholding percentage in the subsidiary remains unchanged at 51%. 

Trident Lifeline is engaged in the pharmaceutical business ethical marketing in domestic as well as international market.


Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..